Novartis

About Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2014, the Group achieved net sales of USD 58 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 120,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world.

About Corporate Responsibility at Novartis

We aim to improve global health. Through our business, we make an important contribution to society: We discover and develop innovative medicines. Novartis collaborates with others to help address some of the world’s greatest health challenges. We focus our corporate responsibility work on two areas that underscore our mission of caring and curing.

Expanding access to healthcare. We work to control and eliminate diseases such as malaria and leprosy, pioneer new business approaches and healthcare delivery models to reach underserved patients, and find new treatments and adaptive solutions to improve health in developing countries. In 2014, these efforts reached more than 70 million people.

Doing business responsibly. This is a core part of Novartis. We care for our associates, strive to positively contribute to the communities where we live and work, and protect the environment. We conduct business ethically, maintaining a Code of Conduct and governance system to ensure our associates uphold our values.

Flexible Media Releases

Novartis in Society US Report 2020

Campaigns

Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US
Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on...

Novartis US Foundation
Initiatives summarizing efforts from the Novartis US Foundation.

Novartis COVID-19 Trials
Novartis clinical trial efforts in COVID-19 R&D.

Novartis US Foundation COVID-19 Response
In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one...

Novartis – science based innovation for better patient outcomes
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

The Novartis Malaria Initiative
For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...

Novartis Access: Medicines to treat chronic diseases in lower-income countries
Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to...

Novartis Foundation Leprosy Elimination Initiative
The Novartis Foundation is convening experts from the global health and anti-leprosy community to discuss the current state of leprosy treatment and...

Videos